EASTMAN CHEMICAL CO
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.75B | $9.38B | $9.21B | $10.58B | $10.48B | $8.47B | $9.27B | $10.15B |
| Cost of Revenue | $6.91B | $7.09B | $7.15B | $8.44B | $7.98B | $6.50B | $7.04B | $7.67B |
| Gross Profit | $1.84B | $2.29B | $2.06B | $2.14B | $2.50B | $1.98B | $2.23B | $2.48B |
| Gross Margin | 21.1% | 24.4% | 22.4% | 20.2% | 23.9% | 23.3% | 24.1% | 24.4% |
| Operating Expenses | ||||||||
| Research & Development | $255.0M | $250.0M | $239.0M | $264.0M | $254.0M | $226.0M | $234.0M | $235.0M |
| SG&A Expense | $658.0M | $736.0M | $727.0M | $726.0M | $795.0M | $654.0M | $691.0M | $721.0M |
| Operating Income | $568.0M | $1.08B | $1.09B | $977.0M | $1.08B | $530.0M | $902.0M | $1.31B |
| Operating Margin | 6.5% | 11.5% | 11.8% | 9.2% | 10.3% | 6.3% | 9.7% | 12.9% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $568.0M | $1.08B | $1.09B | $977.0M | $1.08B | $530.0M | $902.0M | $1.31B |
| Income Tax Expense | $93.0M | $170.0M | $191.0M | $181.0M | $215.0M | $41.0M | $140.0M | $226.0M |
| Net Income | $474.0M | $905.0M | $894.0M | $793.0M | $857.0M | $478.0M | $759.0M | $1.08B |
| Net Margin | 5.4% | 9.6% | 9.7% | 7.5% | 8.2% | 5.6% | 8.2% | 10.6% |
| EPS (Basic) | $4.14 | $7.75 | $7.54 | $6.42 | $6.35 | $3.53 | $5.52 | $7.65 |
| EPS (Diluted) | $4.10 | $7.67 | $7.49 | $6.35 | $6.25 | $3.50 | $5.48 | $7.56 |
| Shares Outstanding (Basic) | 114.7M | 116.7M | 118.6M | 123.5M | 134.9M | 135.5M | 137.4M | 141.2M |
| Shares Outstanding (Diluted) | 115.6M | 117.9M | 119.4M | 124.9M | 137.1M | 136.5M | 138.5M | 142.9M |
| Dividends Per Share | $3.33 | $3.26 | $3.18 | $3.07 | $2.83 | $2.67 | $2.52 | $2.30 |